TIBULIZUMAB
UNII 42HQ15W1ZF

Substance Identification & Data

This profile provides standardized clinical and technical data for Tibulizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 42HQ15W1ZF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1849636-24-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

42HQ15W1ZF

CAS Registry Number

1849636-24-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TIBULIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152608

National Cancer Institute reference terminology for clinical and research data.

INN ID

10656

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-86

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tibulizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TIBULIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY/HUMAN INTERLEUKIN 17) HEAVY CHAIN, DISULFIDE WITH ANTI-(B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY) LIGHT CHAIN, DIMER

TIBULIZUMAB [INN]

TIBULIZUMAB [USAN]